Arcus Biosciences, Inc. — Director's Dealing 2019

Jun 10, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2019-06-06

Reporting Person: Jarrett Jennifer (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-06	Stock Option (Right to buy)	$7.99	A	35000	Acquired	2029-06-05	Common Stock (35000)	Direct

Footnotes

F1: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.